Pharmaceutical Research and Manufacturers of America, Petitioner v. Sean O'Day, in His Official Capacity as Director of the Oregon Department of Consumer and Business Services

A drug-industry group challenges an Oregon law requiring drugmakers to submit reports explaining certain price increases. The group says public disclosure of some report information can compel speech and expose confidential business information, including trade secrets.

The case is pending, and oral argument has not been scheduled. The petition argues that Oregon's reporting and disclosure rules compel speech and can publish confidential business information; a divided Ninth Circuit panel upheld the law.

The case could affect drugmakers that must explain price increases and consumers seeking information about why drug costs rise. It also could shape when states may publish confidential information reported to regulators.

The case asks whether Oregon may require drugmakers to explain price increases and publicly disclose reports that may contain trade secrets.

Drugmakers could face reporting and disclosure requirements, while consumers could gain access to information about certain drug-price increases.

The Supreme Court will decide whether to hear the case. No oral argument has been scheduled.